Stay updated with breaking news from Peter Maag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc (NASDAQ:CDNA – Free Report) Director Peter Maag sold 2,432 shares of the business’s stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.72, for a total transaction of $21,207.04. Following the sale, the director now owns 313,136 shares of the company’s stock, valued at approximately […]
CareDx, Inc (NASDAQ:CDNA – Free Report) Director Peter Maag sold 2,432 shares of the stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $8.72, for a total value of $21,207.04. Following the completion of the sale, the director now directly owns 313,136 shares in the company, valued […]
The FDA has granted Fast Track designation to KYV-101 for the treatment of patients with refractory lupus nephritis.
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company with the mission of engineering a new class of therapies for serious autoimmune...
Los Angeles Capital Management LLC purchased a new position in shares of CareDx, Inc (NASDAQ:CDNA – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 102,232 shares of the company’s stock, valued at approximately $1,166,000. Several other institutional investors and hedge […]